Five national pharmacy groups are urging the Federal Trade Commission to scrutinize megamergers in healthcare and expressed concern that they are negatively affecting pharmacists and their patients. In a letter sent to the FTC Feb. 26, the groups said consolidation in healthcare has “yielded significant anticompetitive effects without promised improvements in cost or quality.” The three largest pharmacy benefit managers in the U.S. control more than three-fourths of all prescriptions filled in the U.S., and each has been combined with other, equally powerful healthcare companies, they said.
Read the full article: Pharmacy Groups Urge FTC to Scrutinize Megamergers //
Source: https://www.beckershospitalreview.com/pharmacy/pharmacy-groups-urge-ftc-to-scrutinize-megamergers.html